Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - PROGENICS PHARMACEUTICALS INC | Financial_Report.xls |
EX-23.1 - EXHIBIT 23.1 CONSENT OF PRICEWATERHOUSECOOPERS - PROGENICS PHARMACEUTICALS INC | ex23_112312011.htm |
EX-32.1 - EXHIBIT 32.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_112312011.htm |
EX-31.1 - EXHIBIT 31.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_112312011.htm |
EX-31.2 - EXHIBIT 31.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_212312011.htm |
EX-32.2 - EXHIBIT 32.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_212312011.htm |
10-K - PROGENICS FORM 10-K DECEMBER 31, 2011 - PROGENICS PHARMACEUTICALS INC | form10_k12312011.htm |
Exhibit 12.1
Progenics Pharmaceuticals, Inc.
Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
Years Ended December 31,
|
|||||||||||||||||
2011
|
2010
|
2009
|
2008
|
2007
|
|||||||||||||
Determination of earnings (loss):
|
|||||||||||||||||
Income (loss) from operations
|
$
|
10,381
|
$
|
(69,820
|
)
|
$
|
(30,612
|
)
|
$
|
(44,672
|
)
|
$
|
(43,688
|
)
|
|||
Add:
|
|||||||||||||||||
Fixed charges
|
695
|
709
|
555
|
594
|
483
|
||||||||||||
Earnings (loss), as adjusted
|
$
|
11,076
|
$
|
(69,111
|
)
|
$
|
(30,057
|
)
|
$
|
(44,078
|
)
|
$
|
(43,205
|
)
|
|||
Fixed charges:
|
|||||||||||||||||
Estimate of interest within rental expense
|
695
|
709
|
555
|
594
|
483
|
||||||||||||
Fixed charges
|
$
|
695
|
$
|
709
|
$
|
555
|
$
|
594
|
$
|
483
|
|||||||
Preferred stock dividends
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||||
Ratio of earnings (loss) to fixed charges and preferred stock dividends
|
16
|
*
|
*
|
*
|
*
|
||||||||||||
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
|
-
|
$
|
69,820
|
$
|
30,612
|
$
|
44,672
|
$
|
43,688
|
|
______________
(1) For the years ended 2007 through 2010, the Company’s coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.
|